ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,773Gold OA

Clinical and Translational Allergy

Acronym:clintransall
•
Abbreviation (ISO):CLIN TRANSL ALLERGY
•
Identifier (ISSN):2045-7022(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
4.2↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical and Translational Allergy

WoS Q2
24683.5420184.2320195.1320205.8720215.6620224.420234.62024420254.22026
Annual Impact Factor Metric
Current (2026):4.2
Scopus SJR & RankScopus Q1
1.396
#2,773

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
60

60 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate6.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
68articles/year
100% Gold OA•84.62% Original Research

Aims & Scope

Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.

Topics Covered (Recognized by AI)
Medicine99.6%Biology90.9%Immunology86.2%Allergy68.6%Internal medicine67.1%Genetics59.4%Pathology46.5%Chemistry42.5%Antibody37.2%Biochemistry36%Immunoglobulin E34.8%Psychology32.4%Food allergy29.1%Asthma27.6%Allergen23.7%Surgery23.2%Dermatology23%Pediatrics20.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ALLERGY

Q2
Rank13/40
IndexSCIE
JCISCIE2026

ALLERGY

Q1
Rank10/40
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.2
Articles / Year75
Total Citations27
2025
IF4
Articles / Year136
Total Citations350
2024
IF4.6
Articles / Year102
Total Citations595
2023
IF4.4
Articles / Year124
Total Citations1,010
2022
IF5.657
Articles / Year122
Total Citations1,780

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,773Scopus Q1SCImago Profile
Scopus Coverage:2011-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.396

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.49

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,452 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,059
3-Year Documents270
Citable Documents205

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate55.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Pulmonary and Respiratory MedicineQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ALLERGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical and Translational Allergy (acronym: clintransall, abbr: CLIN TRANSL ALLERGY, ISSN: 2045-7022) is a peer-reviewed international scholarly journal in the field of Immunology and Microbiology, published by BioMed Central in England since 2011. The periodical holds a Journal Impact Factor (JIF) of 4.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.396 (Q1), an H-index of 60.

The journal enforces rigorous peer evaluation with a publication frequency of Continuous publication, an annual output of approximately 68 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,452 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Continuous publication
Founding Year
2011
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
WILEY, 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cf651106-d2cf-4ad3-afda-db49a4f4fa40
Database Updated: 2026-10-01